We know that tumor-infiltrating immune cells (e.g., γδ IL-17-producing T cells, CD8+ T lymphocytes, or type I macrophages) can kill tumor cells (5), and that high TNFα doses can inhibit tumor growth (6). Here, IL17A is linked to neoplasm.